Hemostasis Today

August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Wolfgang Miesbach: Potential Transmission of Haemorrhagic Risk Through Blood Transfusion
Aug 27, 2026, 13:13

Wolfgang Miesbach: Potential Transmission of Haemorrhagic Risk Through Blood Transfusion

Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared post on LinkedIn about a recent article by Gargi Banerjee et al., published in The Lancet, adding:

”Haemorrhage risk appears transferrable from blood donor to recipient.  A Lancet Viewpoint from a workshop convened by the MRC Prion Unit at UCL in 2024, with clinicians, epidemiologists and transfusion specialists:

Amyloid β (Aβ) propagates by templated seeding, the mechanism of the prion protein. It circulates in plasma, comes from platelets, binds to red cells. In rodents, blood from amyloid-bearing animals seeds cerebral amyloidosis in the recipient.

Denmark and Sweden, 1.27 million donors and 1.09 million recipients: recipients of red cells from donors who later had repeated intracerebral haemorrhages, the pattern typical of cerebral amyloid angiopathy, had a higher haemorrhage risk themselves. Registry data only, no imaging, no histology.

Open questions: are plasma-derived products, including factor concentrates, affected?

Not yet examined. Latency unknown.

No assay measures Aβ seeds in plasma. p-tau217 could screen donors, but the meaning of a positive result in a healthy donor is undefined.”

Title: Risk of transmission of amyloid β pathology via transfused blood products

Authors: Gargi Banerjee, Gustaf Edgren, Jingcheng Zhao, Prof Neil M Ferguson, Prof Heli Harvala, James Hope, Graham S Jackson, Prof Philip J Lowry, Prof Simon Mead, Silvia A Purro, Prof Jonathan M Schott, Prof Marc L Turner, Prof David J Werring, Prof Henrik Zetterberg, Prof John Collinge

 

Wolfgang Miesbach: Potential Transmission of Haemorrhagic Risk Through Blood TransfusionOther posts featuring Wolfgang Miesbach on Hemostasis Today.